These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26782254)

  • 21. The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).
    't Lam-Boer J; Mol L; Verhoef C; de Haan AF; Yilmaz M; Punt CJ; de Wilt JH; Koopman M
    BMC Cancer; 2014 Oct; 14():741. PubMed ID: 25277170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival.
    Clancy C; Burke JP; Barry M; Kalady MF; Calvin Coffey J
    Ann Surg Oncol; 2014 Nov; 21(12):3900-8. PubMed ID: 24849523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
    Urvay S; Eren T; Civelek B; Kilickap S; Yetiysigit T; Ozaslan E
    J BUON; 2020; 25(2):939-944. PubMed ID: 32521889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
    Hrehoreţ D; Alexandrescu S; Braşoveanu V; Grigorie R; Zielinski C; Popescu I
    Chirurgia (Bucur); 2013; 108(5):719-24. PubMed ID: 24157119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).
    Rahbari NN; Lordick F; Fink C; Bork U; Stange A; Jäger D; Luntz SP; Englert S; Rossion I; Koch M; Büchler MW; Kieser M; Weitz J;
    BMC Cancer; 2012 Apr; 12():142. PubMed ID: 22480173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients.
    Kodaz H; Erdogan B; Hacibekiroglu I; Turkmen E; Tozkir H; Albayrak D; Uzunoglu S; Cicin I
    Hepatogastroenterology; 2015 Jun; 62(140):876-9. PubMed ID: 26902020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.
    Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of colorectal cancer with unresectable metastasis with chemotherapy without primary tumor resection: analysis of tumor-related complications].
    Cáceres M; Pascual M; Alonso S; Montagut C; Gallén M; Courtier R; Gil MJ; Grande L; Andreu M; Pera M
    Cir Esp; 2014 Jan; 92(1):30-7. PubMed ID: 24176190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous surgery for primary colorectal cancer and metastatic lesions?
    Gustavsson B
    Scand J Gastroenterol; 2012 Mar; 47(3):269-76. PubMed ID: 22242554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Australian contemporary management of synchronous metastatic colorectal cancer.
    Malouf P; Gibbs P; Shapiro J; Sockler J; Bell S
    ANZ J Surg; 2018 Jan; 88(1-2):71-76. PubMed ID: 27122066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.
    He Y; Liu P; Zhang Y; Deng X; Meng W; Wei M; Yang T; Wang Z; Qiu M
    Trials; 2015 May; 16():238. PubMed ID: 26021722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer.
    Seo GJ; Park JW; Yoo SB; Kim SY; Choi HS; Chang HJ; Shin A; Jeong SY; Kim DY; Oh JH
    J Surg Oncol; 2010 Jul; 102(1):94-9. PubMed ID: 20578086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
    Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
    Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
    Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Al-Batran SE; Lange T; Dietrich G; Stoehlmacher J; Tannapfel A; Reinacher-Schick A; Quidde J; Trarbach T; Hinke A; Schmoll HJ; Arnold D
    Lancet Oncol; 2015 Oct; 16(13):1355-69. PubMed ID: 26361971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection.
    Nitzkorski JR; Farma JM; Watson JC; Siripurapu V; Zhu F; Matteotti RS; Sigurdson ER
    Ann Surg Oncol; 2012 Feb; 19(2):379-83. PubMed ID: 21861213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
    Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases.
    Huang M; Yang Y; Li Q; Wang C; Liang L; Zhu X; Zhang W; Chen Z; Huang D; Li W; Zhang X; Zhao X; Qiu L; Geng Q; Yu N; Du W; Sun S; Sheng X; Li X; Guo W
    Front Oncol; 2022; 12():747124. PubMed ID: 35174078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
    Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.
    Mulsow J; Merkel S; Agaimy A; Hohenberger W
    Br J Surg; 2011 Dec; 98(12):1785-91. PubMed ID: 22034185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.